Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12197809 | 0.84 | ALDH1A1 (0.35) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12197798 | 0.84 | CCR1 (0.36) | KDM4EHPGDMAPTCCR1CCR5 | |
| SCHEMBL12197825 | 0.79 | ALDH1A1 (0.44) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12197829 | 0.79 | RAB9A (0.34) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12197792 | 0.78 | MAPK10 (0.38) | KDM4EHPGDALDH1A1MAPTNPC1 | |
| SCHEMBL12197827 | 0.77 | ESR1 (0.38) | ALDH1A1MAPTLMNAMEN1KMT2A | |
| SCHEMBL12197817 | 0.77 | RAB9A (0.36) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12201471 | 0.76 | CCR1 (0.42) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12315011 | 0.71 | KMT2A (0.36) | KDM4EHPGDALDH1A1MAPTLMNA | |
| SCHEMBL12197805 | 0.70 | KMT2A (0.40) | KDM4EHPGDALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8384074-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-02-26 | — | — | US | disclosed |
| US-8384074-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-02-26 | — | — | US | disclosed |
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD (KR) | 2011-10-06 | — | — | US | disclosed |
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD (KR) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240978-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LEF1, IDO1, NOD1 | KDM4E 2764/4885HPGD 1455/4885ALDH1A1 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.